Becki Morison has been appointed Executive Vice President, Global Therapeutic & Value Strategy, LEO Pharma.
Morison joins LEO Pharma from Eli Lilly, where she was VP, US Immunology. Prior to that, she held several leadership positions in the US, in Australia, in the United Kingdom, and in the Nordics. In addition to her international experience, Morison has a proven track record in building and growing innovative pharmaceutical franchises in different therapeutic areas, including orphan diseases.
Broad knowledge in immunology, dermatology and specialty pharma
“Becki Morison’s broad knowledge in immunology, dermatology and specialty pharma will help us to strategically develop our innovative portfolio and execute global launches of best or first-in-class medicines, which is essential to reach our ambition of becoming a global leader in medical dermatology,” says Catherine Mazzacco, CEO, LEO Pharma.
Morison succeeds Patrice Baudry, who will take over responsibility for establishing LEO Pharma’s rare disease presence.
Photo: LEO Pharma
